Jasper Therapeutics

Jasper Therapeutics(JSPRW)

REDWOOD CITY, CA
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Humanized Monoclonal Antibody

Jasper Therapeutics is a life sciences company focused on Humanized Monoclonal Antibody.

OncologyDermatologyRespiratoryOphthalmology
Funding Stage
PUBLIC
Open Jobs
1

Pipeline & Clinical Trials

Supramaximal resection
Glioblastoma
N/A
Re-resection
Glioblastoma
N/A
Clinician and Non-clinician staff training
LGBT Health
N/A
Awake craniotomy
Glioblastoma
N/A
Clinical Trials (1)
NCT03861299The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
N/A
Palliative Care
Glioblastoma
N/A
Tumor resection
Glioblastoma
N/A
Briquilimab
Allergic Asthma
Phase 1
Clinical Trials (1)
NCT06592768A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
Phase 1
Humanized anti-CD117 Monoclonal Antibody
MYELODYSPLASTIC SYNDROME; MDS
Phase 1
Clinical Trials (1)
NCT04429191JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation
Phase 1
Phase 1
Clinical Trials (1)
NCT05903274JSP191 (briquilimab) in Subjects with LR-MDS
Phase 1
Humanized anti-CD117 Monoclonal Antibody
SCID
Phase 1/2
Clinical Trials (1)
NCT02963064JSP191 Antibody Targeting Conditioning in SCID Patients
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT06353971A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT06162728Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)
Phase 1/2
Phase 2
Clinical Trials (1)
NCT06736262A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials
Phase 2
Aerobic Exercise
Nicotine Dependence
Phase 3
Clinical Trials (1)
NCT06053567Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Phase 3
Nelfinavir and Omeprazole
Healthy Volunteers
Phase 4

Open Jobs (1)

Senior Director Data Management (Contract)

Redwood City, CA
Jasper Therapeutics
4w ago
Interview Prep Quick Facts
Portfolio: 9 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available
Open Roles: 1 active job

Financials (FY2024)

R&D Spend
$52M50%
Net Income
-$64M
Cash
$87M
Source: SEC 10-K Filing

Hiring Trend

Stable
1
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub